Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A

about

Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A

Item

http://www.wikidata.org/entity/Q35667995

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@ast

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@en

type

Item

label

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@ast

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@en

prefLabel

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@ast

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@en

P1476

Pharmacokinetic Study and Opti ...... tural Compound Schisantherin A

@en

P2093

Bao Jian Guo

http://www.w3.org/2001/XMLSchema#string

Fei Sa

http://www.w3.org/2001/XMLSchema#string

Hok Man Chan

http://www.w3.org/2001/XMLSchema#string

Sai Li

http://www.w3.org/2001/XMLSchema#string

Simon Ming Yuen Lee

http://www.w3.org/2001/XMLSchema#string

Zai Jun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in rats

Unexpected neuronal protection of SU5416 against 1-Methyl-4-phenylpyridinium ion-induced toxicity via inhibiting neuronal nitric oxide synthase

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.

Prodrug approaches for enhancing the bioavailability of drugs with low solubility.

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine

Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways.

Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo.

The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis.

Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells.

P304

951361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/951361

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Ying Zheng

P577

2015-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277913327

http://www.w3.org/2001/XMLSchema#string

P698

26075137

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4449939

http://www.w3.org/2001/XMLSchema#string